We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.48%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.7B
AUM Growth
-$392M
(-1.7%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
13.52%
Holding
1,954
New
218
Increased
445
Reduced
978
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Weyerhaeuser
WY
|
+$41.7M |
| 3 |
Mondelez International
MDLZ
|
+$34M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$33.6M |
| 5 |
Lazard
LAZ
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$96.8M |
| 2 |
HCA Healthcare
HCA
|
+$70.3M |
| 3 |
HP
HPQ
|
+$51.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.2M |
| 5 |
T. Rowe Price
TROW
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.75% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.81T
| $727M | 3.21% |
23,383,560
-414,496
| -2% | -$12.5M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $317M | 1.4% |
1,065,861
+166,974
| +19% | +$47.6M |
|
3
ExxonMobil
XOM
$629B
| $297M | 1.31% |
3,490,838
-40,947
| -1% | -$3.63M |
|
4
Microsoft
MSFT
$2.95T
| $296M | 1.31% |
7,291,576
-449,187
| -6% | -$19.6M |
|
5
Alphabet (Google) Class C
GOOG
$4.22T
| $293M | 1.29% |
10,665,181
-659,004
| -6% | -$17.7M |
|
6
Procter & Gamble
PG
$345B
| $244M | 1.07% |
2,973,240
-25,393
| -0.8% | -$2.18M |
|
7
Wells Fargo
WFC
$261B
| $228M | 1.01% |
4,195,240
-66,000
| -2% | -$3.57M |
|
8
Verizon
VZ
$182B
| $226M | 1% |
4,641,167
-35,012
| -0.7% | -$1.69M |
|
9
JPMorgan Chase
JPM
$901B
| $221M | 0.97% |
3,643,180
-37,816
| -1% | -$2.24M |
|
10
Johnson & Johnson
JNJ
$599B
| $217M | 0.96% |
2,159,971
-30,459
| -1% | -$3.1M |
|
11
GE Aerospace
GE
$354B
| $217M | 0.96% |
1,824,996
-19,064
| -1% | -$2.27M |
|
12
Chevron
CVX
$381B
| $211M | 0.93% |
2,008,914
-42,894
| -2% | -$4.58M |
|
13
Citigroup
C
$216B
| $208M | 0.92% |
4,031,561
-29,621
| -0.7% | -$1.51M |
|
14
Berkshire Hathaway Class B
BRK.B
$1.06T
| $185M | 0.82% |
1,283,415
-23,862
| -2% | -$3.51M |
|
15
Coca-Cola
KO
$353B
| $183M | 0.81% |
4,512,451
-37,901
| -0.8% | -$1.59M |
|
16
IBM
IBM
$198B
| $175M | 0.77% |
1,143,161
+97,567
| +9% | +$14.8M |
|
17
Medtronic
MDT
$107B
| $172M | 0.76% |
2,206,658
+209,307
| +10% | +$15.9M |
|
18
Home Depot
HD
$332B
| $168M | 0.74% |
1,482,213
+114,299
| +8% | +$12.6M |
|
19
Visa
V
$677B
| $167M | 0.73% |
2,545,580
+214,352
| +9% | +$14.2M |
|
20
Gilead Sciences
GILD
$165B
| $166M | 0.73% |
1,687,052
-90,638
| -5% | -$9.2M |
|
21
Oracle
ORCL
$366B
| $159M | 0.7% |
3,673,617
-47,628
| -1% | -$2.06M |
|
22
Walt Disney
DIS
$167B
| $157M | 0.69% |
1,500,523
-56,185
| -4% | -$5.67M |
|
23
Bank of America
BAC
$430B
| $155M | 0.68% |
10,076,139
+131,828
| +1% | +$2.12M |
|
24
Pfizer
PFE
$142B
| $155M | 0.68% |
4,684,902
-127,929
| -3% | -$4.07M |
|
25
Comcast
CMCSA
$84.9B
| $150M | 0.66% |
5,316,298
-101,206
| -2% | -$2.91M |
|
Similar funds
RG
KK
VAI
STRS Ohio's Q1 2015 Portfolio in Review
As of Q1 2015, STRS Ohio held 1,954 positions worth $22.7B, down 1.7% from $23.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio withdrew a net $683M in Q1 2015, closing 152 positions and reducing 978 holdings. Its most notable exit was Allergan Inc, an estimated $96.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, STRS Ohio opened a new position in Lazard worth $30.5M.
- STRS Ohio's largest Q1 2015 buy was Lazard: 580,430 shares worth $30.5M.
- STRS Ohio added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- STRS Ohio's biggest Q1 2015 reduction was HCA Healthcare, cutting an estimated $70.3M.
- STRS Ohio fully exited Allergan Inc in Q1 2015, selling an estimated $96.8M.
- STRS Ohio's ten largest holdings make up 14% of its $22.7B portfolio in Q1 2015.
- STRS Ohio opened 218 new positions and closed 152 in Q1 2015.
- STRS Ohio's portfolio value fell 1.7% quarter-over-quarter to $22.7B.
Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.